Treatment of diabetic coma with continuous low-dose infusion of insulin. 1974

M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West

Thirty-eight patients in diabetic coma from four different centres were treated with a continuous low-dose intravenous infusion of insulin at an average dose of 7.2 IU/hr. All patients recovered rapidly except for one profoundly shocked patient who died. The mean fall in plasma glucose was 58% four hours after the start of insulin. Blood ketone bodies and plasma free fatty acids showed a similar response. There was no significant difference in plasma glucose response according to severity of acidosis or previous treatment with insulin. Hypokalaemia was uncommon. In the treatment of diabetic coma this technique has proved simple, safe, and effective.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007657 Ketone Bodies The metabolic substances ACETONE; 3-HYDROXYBUTYRIC ACID; and acetoacetic acid (ACETOACETATES). They are produced in the liver and kidney during FATTY ACIDS oxidation and used as a source of energy by the heart, muscle and brain. Acetone Bodies,Bodies, Acetone,Bodies, Ketone
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003926 Diabetic Coma A state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy. Coma, Diabetic,Comas, Diabetic,Diabetic Comas

Related Publications

M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
December 1978, Monatsschrift fur Kinderheilkunde,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
December 1974, Annals of internal medicine,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
August 1976, Ugeskrift for laeger,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
August 1978, New York state journal of medicine,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
November 1974, JAMA,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
November 1976, Deutsche medizinische Wochenschrift (1946),
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
May 1979, Klinische Padiatrie,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
March 1979, Lijecnicki vjesnik,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
September 1981, Postgraduate medical journal,
M M Page, and K G Alberti, and R Greenwood, and K A Gumaa, and T D Hockaday, and C Lowy, and J D Nabarro, and D A Pyke, and P H Sönksen, and P J Watkins, and T E West
June 1976, Endokrinologie,
Copied contents to your clipboard!